SCM

Stonepine Capital Management Portfolio holdings

AUM $126M
1-Year Est. Return 70.12%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+70.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$94.6M
AUM Growth
-$48.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
33
New
Increased
Reduced
Closed

Top Buys

1
+$14.6M
2
+$5.75M
3
+$4.36M
4
BXRX
Baudax Bio, Inc. Common Stock
BXRX
+$4.12M
5
CDTX
Cidara Therapeutics
CDTX
+$3.9M

Top Sells

1
+$4.83M
2
+$3.96M
3
+$3.58M
4
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
+$2.76M
5
APVO icon
Aptevo Therapeutics
APVO
+$2.73M

Sector Composition

1 Healthcare 91.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$16K 0.02%
+1,000
27
– –
-431,853
28
– –
-3,909,207
29
– –
-730
30
– –
-1
31
– –
-60,938
32
– –
-20,000
1
2